May 28, 2026 07:05AM
May 21, 2026 05:32AM
May 11, 2026 09:22AM
May 6, 2026 04:28AM
May 5, 2026 05:24PM
May 5, 2026 04:05PM
Apr 28, 2026 09:05AM Protagonist Exercises Rusfertide U.S. Opt-Out Right Under Takeda Collaboration
Apr 16, 2026 04:05PM
Apr 14, 2026 03:13PM
Apr 14, 2026 01:03PM
Apr 6, 2026 04:06PM
Mar 28, 2026 10:05AM
Mar 28, 2026 10:05AM
Mar 18, 2026 03:39PM Protagonist Therapeutics (PTGX) PT Raised to $104 at Clear Street
Mar 18, 2026 12:17PM
Mar 18, 2026 12:14PM
Mar 18, 2026 10:28AM
Mar 18, 2026 08:05AM
Mar 18, 2026 08:05AM
Mar 2, 2026 06:47AM
Mar 2, 2026 06:01AM FDA accepts rusfertide application with priority review for blood disorder
Feb 26, 2026 04:51AM
Feb 25, 2026 05:15PM
Feb 25, 2026 04:05PM
Jan 30, 2026 06:47AM
Jan 27, 2026 06:52AM
Jan 5, 2026 09:38AM
Jan 5, 2026 07:03AM Takeda and Protagonist submit drug application for polycythemia vera treatment
Dec 12, 2025 04:54AM
Dec 8, 2025 02:54AM
Nov 20, 2025 04:00AM
Nov 7, 2025 05:04AM
Nov 6, 2025 06:42PM
Nov 6, 2025 04:05PM
Oct 28, 2025 09:26AM Protagonist Therapeutics (PTGX) PT Raised to $88 at Truist Securities
Oct 13, 2025 02:04PM
Oct 13, 2025 05:04AM
Oct 10, 2025 01:06PM
Oct 10, 2025 11:27AM
Oct 10, 2025 11:16AM
Oct 10, 2025 11:14AM
Oct 8, 2025 09:08AM BMO Capital on Protagonist Therapeutics (PTGX): 'UEG Icotrokinra Full Data Remains Compelling'
Oct 7, 2025 11:00PM
Oct 7, 2025 02:50PM
Sep 17, 2025 04:35AM
Sep 12, 2025 06:02AM
Aug 7, 2025 04:18AM
Aug 6, 2025 06:25PM
Aug 6, 2025 04:05PM Protagonist Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Jul 1, 2025 06:47AM

396,467 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All